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Abstract
Aim: To determine the prevalence of severe acute maternal morbidity (SAMM) worldwide (near
miss).
Method: Systematic review of all available data. The methodology followed a pre-defined protocol,
an extensive search strategy of 10 electronic databases as well as other sources. Articles were
evaluated according to specified inclusion criteria. Data were extracted using data extraction
instrument which collects additional information on the quality of reporting including definitions
and identification of cases. Data were entered into a specially constructed database and tabulated
using SAS statistical management and analysis software.
Results: A total of 30 studies are included in the systematic review. Designs are mainly cross-
sectional and 24 were conducted in hospital settings, mostly teaching hospitals. Fourteen studies
report on a defined SAMM condition while the remainder use a response to an event such as
admission to intensive care unit as a proxy for SAMM. Criteria for identification of cases vary widely
across studies. Prevalences vary between 0.80% – 8.23% in studies that use disease-specific criteria
while the range is 0.38% – 1.09% in the group that use organ-system based criteria and included
unselected group of women. Rates are within the range of 0.01% and 2.99% in studies using
management-based criteria. It is not possible to pool data together to provide summary estimates
or comparisons between different settings due to variations in case-identification criteria.
Nevertheless, there seems to be an inverse trend in prevalence with development status of a
country.
Conclusion: There is a clear need to set uniform criteria to classify patients as SAMM. This
standardisation could be made for similar settings separately. An organ-system dysfunction/failure
approach is the most epidemiologically sound as it is least open to bias, and thus could permit
developing summary estimates.
Background
Severe acute maternal morbidity (SAMM), also known as
"near miss", is defined as "A very ill pregnant or recently
delivered woman who would have died had it not been
that luck and good care was on her side" [1,2]. This con-
cept is relatively new in maternal care, but is increasingly
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becoming important in areas with low maternal mortality
ratios or where the geographic area is small [3,4]. The use
of data collected on SAMM has been shown to be a mech-
anism for identifying health system failures or priorities in
maternal health care more rapidly than maternal deaths
[5]. It has the advantage of events still being rare enough
not to overload clinicians and data capturing personnel
within a facility. Its routine use as an indicator, however,
is limited due to the lack of uniform criteria of identifica-
tion of the cases.
This study was undertaken to systematically review all
available studies on SAMM with a view to establishing the
global prevalence and examining the usefulness as a
maternal health indicator.
Methods
This study is a part of a bigger systematic review under-
taken by the UNDP/UNFPA/WHO/World Bank Special
Programme of Research, Development and Research
Training in Human Reproduction (HRP), Department of
Reproductive Health and Research at the World Health
Organization (WHO) to obtain prevalence/incidence data
on maternal mortality and a range of morbidities includ-
ing SAMM. The methodology of the systematic review fol-
lowed an a priori protocol and involved an extensive
search of all relevant published/unpublished data from
1997 to 2002. The methodology of the systematic review
and the search strategy have been described elsewhere [6].
In brief, we searched 10 electronic databases, WHO
regional databases, internet and reference lists, contacted
experts in the field, and hand-searched relevant articles in
the WHO Library. Criteria for inclusion of studies in the
review were: inclusion of data relevant to pre-defined con-
ditions, specified dates for data collection period, includ-
ing data from 1990 onwards, sample size >200 and a clear
description of methodology.
A data extraction instrument was used to extract data from
included studies. This instrument includes 48 items dis-
tributed in five modules three of which were relevant to
this analysis. Modules were designed to collect informa-
tion on (i) the general study level characteristics such as
design, population, setting, (ii) prevalence/incidence of
maternal morbid conditions, and (iii) quality assessment
of morbidity reports. Reporting of definitions and of the
procedures used for identification of cases for morbidities
were part of quality assessment. We did not assign quality
scores to articles, but preferred to present available infor-
mation on variables regarded as quality components
(including reporting of definitions, case-identification cri-
teria, characteristics of setting and participants).
Nearly 65 000 reports were screened initially by titles and/
or abstracts of which more than 4500 were retrieved for
full-text evaluation. More than 2500 of these were
included in the review. Data extracted were entered into a
specifically constructed database and tabulated using SAS
software.
A small number of the articles in the review report on
SAMM, near miss or a similar definition such as severe
morbidity, critically ill obstetric patient. Although we
included other articles reporting on individual severe
morbidities within their own category of conditions (e.g.
severe hypertension within hypertensive disorders of
pregnancy), this particular article is concerned with those
papers which define a separate entity of SAMM or similar,
or those which report on the most recognised end-points
for SAMM (i.e. emergency hysterectomy and obstetric
admissions to intensive care units).
We later conducted an updated search of MEDLINE and
Popline using the keywords 'near miss morbidity' and
'severe maternal morbidity' to find out about any recent
publications that could be of importance, but were not
included in the database due to the end date of the origi-
nal search (2002) for the bigger systematic review. The
date of this complementary search was June 2004.
We describe below the included studies with an emphasis
on the different definitions used and criteria for identifi-
cation of the cases.
Results
A total of 30 reports of SAMM are included in the system-
atic review (twenty-seven identified by the original search
and three by the complementary search). Study designs
are mainly cross-sectional and most of them are con-
ducted in tertiary care hospitals (see Additional file 1).
Most of the studies describe the characteristics of the set-
ting and participants as well as reporting definitions and
procedures for identification of the cases.
There are essentially two types of definition of severe acute
maternal morbidity; one describing what the authors
meant by a near miss; and the other describing a response
to an event such as hysterectomy or admission to inten-
sive care unit (ICU). Fourteen studies define a specific
SAMM or near-miss 'condition' [1,2,7-18] while nine con-
sider admissions to ICU as near-miss cases [19-27] and
the remainder report on emergency hysterectomies [28-
34].
In the majority of articles there is an intuitive agreement
on what a near miss means – a woman who almost died
but survived. Identification of cases, however, is complex
and varies widely across studies. We listed the articles in
Additional file 1 in three categories according to criteria
used to classify patients as being near miss; disease-spe-Reproductive Health 2004, 1:3 http://www.reproductive-health-journal.com/content/1/1/3
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cific (specified criteria for common conditions, e.g. pre-
eclampsia, haemorrhage); management-specific (speci-
fied criteria related to response to disease, e.g. hysterec-
tomy or admission to ICU); and organ-system
dysfunction/failure based (specified criteria for dysfunc-
tion or failure related to each organ system). One study
reports the proportion of the admissions to ICU sepa-
rately as well as the total number of SAMM cases [8]. We
included this report under the section of organ-system
based identification criteria.
Individual prevalence rates for SAMM vary between
0.80% – 8.23% in the first category of studies that use dis-
ease-specific criteria. Case-finding criteria differ signifi-
cantly within this category as well. In addition, some of
the studies with similar criteria use mainly clinician's eval-
uation for identification [15], while others have estab-
lished threshold levels for the degree of severity of the
conditions of concern [7,18]. This is probably due to con-
textual factors such as the availability of facilities with suf-
ficient diagnostic tools.
The range is 0.38% – 1.09% in the group of reports that
use organ-system based criteria and include unselected
women. Rates are lower (0.01% – 2.99%) and variation is
lesser in the category of studies using management-based
criteria.
An expected finding is the difference between resource-
poor and more advantageous settings in the prevalence of
SAMM. In resource-poor settings, 4–8% of pregnant
women who deliver in the hospitals will experience
SAMM when case-identification criteria are based on spe-
cific diseases. This rate is around 1% when the organ fail-
ure is considered. In more developed country settings, the
rates are around 1% with disease-specific and 0.4% with
organ-system based criteria, respectively. The results also
suggest that the use of organ-system based criteria is more
specific in identifying the real SAMM cases.
Discussion
Due to the wide variation in identification of the cases, it
is not possible to pool data and make a summary estimate
for SAMM. Because of the variation in case identifications
in the three categories of identification criteria as well as
variation within each category (e.g. for disease-specific cri-
teria – the use of physician's evaluation versus technology
requiring tests) it is difficult to make comparisons as well.
Nevertheless, it is evident that the prevalence of SAMM is
higher in studies conducted in less developed country set-
tings. Rates seem to be higher also in studies that use dis-
ease-specific criteria as compared to those using organ-
system based criteria for similar settings. This finding sug-
gests less specificity of disease-specific criteria in identify-
ing real SAMM cases.
Although less specific, the use of disease-specific criteria
has some advantages; it is easy to interpret, cases can be
identified retrospectively, and the quality of care for that
particular disease can be assessed [18,35]. However, the
approach concentrates on certain diseases, and thus, other
problems such as pulmonary embolus, which is an
important cause of maternal death in developed countries
could be ignored [36]. In addition, definition of condi-
tions may not always be straightforward. For example, the
same threshold for severe haemorrhage could have differ-
ent consequences in women with normal haemoglobin
levels or those with severe anaemia. Furthermore,
although detailed objective criteria are established for case
identification in developed country settings [18], the lim-
ited availability of resources in less developed settings
may not permit this level of detail. Therefore, identifica-
tion of cases is likely to be less accurate when the diagno-
sis depends on clinical estimates [2,15]. Use of
management-specific criteria is advantageous in that it is
simple to identify the cases, but it depends on many other
variables such as the availability of ICU beds, the facilities
in an ICU, or differing views about and indications for
hysterectomy. Also, the approach does not include all
SAMM cases. One study reporting SAMM according to
organ-system based criteria and admissions to ICU sepa-
rately shows that admissions to ICU represent only one
third of all SAMM cases [8].
Use of organ-system based criteria allows for identifying
all severe morbidities and then investigating the primary
cause, thus does not discard any particular condition. It is
the most reproducible across similar areas and criteria can
be defined according to resources available. High technol-
ogy requiring laboratory and haemodynamic investiga-
tions can be avoided. However, it is the most labour-
intensive for identifying cases, hence criteria for inclusion
as near miss must be strict. Bias can be introduced if data
collection is incomplete and prevalence can be underesti-
mated.
Two approaches are used as potential methods of assess-
ing the care SAMM cases receive. "Mortality Index-MI" is
defined as the ratio of maternal deaths among the SAMM
cases to the sum of maternal deaths and SAMM cases
[35,37]. It represents the proportion of women who
presents with a SAMM and subsequently dies [37].
Another approach is to calculate the ratio of SAMM to
mortality [8,18]. We attempted to calculate the ratio of
SAMM to mortality for all studies included under the cat-
egories of disease-specific or organ-system based case
identification criteria (see Additional file 1). We did not
calculate MI because it was not clear from some reports
whether reported maternal deaths were identified as
SAMM or not prior to death.Reproductive Health 2004, 1:3 http://www.reproductive-health-journal.com/content/1/1/3
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It is clearly illustrated in the studies that more SAMM cases
are likely to die in resource-poor settings than in more
developed country settings. For example, the studies con-
ducted in Niger, Benin and Malaysia give the morbidity to
mortality ratio as 11–12 [10,15,17] while this is 117–223
in studies conducted in Europe [11,18] in the category
where disease-specific criteria are used. The same applies
to the category of organ-system based criteria; morbidity:
mortality ratio is 5–8 in South Africa [1,14,15] and 49 in
Scotland [8]. These findings suggest that an indicator that
relates SAMM to maternal deaths could be a useful
method in assessing the care SAMM cases receive. How-
ever, the definitions and identification of cases should be
standardised at least for similar settings and the indicator
needs to be clearly defined.
Conclusion
Considering all complexities in definition and case-iden-
tification of SAMM, it is necessary that studies clearly
describe their identification criteria for the cases. There is
a clear need to set criteria to identify SAMM cases. Use of
organ-system based criteria seems to be a more useful
approach in identifying cases as variation in defining cri-
teria can be avoided, particularly for similar settings. It
would then be easier to establish summary estimates for
SAMM prevalence which could serve as a measure of
maternal health and quality of care indicator.
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